NovoCure Ltd (NVCR)
17.73
+0.64
(+3.74%)
USD |
NASDAQ |
Nov 22, 16:00
17.72
-0.01
(-0.06%)
After-Hours: 20:00
NovoCure Total Assets (Quarterly): 1.222B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.222B |
| June 30, 2024 | 1.212B |
| March 31, 2024 | 1.121B |
| December 31, 2023 | 1.146B |
| September 30, 2023 | 1.146B |
| June 30, 2023 | 1.159B |
| March 31, 2023 | 1.174B |
| December 31, 2022 | 1.192B |
| September 30, 2022 | 1.174B |
| June 30, 2022 | 1.163B |
| March 31, 2022 | 1.150B |
| December 31, 2021 | 1.139B |
| September 30, 2021 | 1.120B |
| June 30, 2021 | 1.097B |
| March 31, 2021 | 1.068B |
| December 31, 2020 | 1.052B |
| September 30, 2020 | 431.05M |
| June 30, 2020 | 528.94M |
| March 31, 2020 | 502.45M |
| December 31, 2019 | 479.45M |
| Date | Value |
|---|---|
| September 30, 2019 | 443.86M |
| June 30, 2019 | 406.19M |
| March 31, 2019 | 370.26M |
| December 31, 2018 | 339.79M |
| September 30, 2018 | 315.51M |
| June 30, 2018 | 309.88M |
| March 31, 2018 | 303.48M |
| December 31, 2017 | 265.30M |
| September 30, 2017 | 262.28M |
| June 30, 2017 | 257.04M |
| March 31, 2017 | 264.63M |
| December 31, 2016 | 282.08M |
| September 30, 2016 | 291.09M |
| June 30, 2016 | 250.52M |
| March 31, 2016 | 279.02M |
| December 31, 2015 | 307.34M |
| September 30, 2015 | 173.78M |
| June 30, 2015 | 192.77M |
| December 31, 2014 | 117.88M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
431.05M
Minimum
Sep 2020
1.222B
Maximum
Sep 2024
1.014B
Average
1.143B
Median
Total Assets (Quarterly) Benchmarks
| Abbott Laboratories | 74.36B |
| Perspective Therapeutics Inc | 391.15M |
| Retractable Technologies Inc | 157.81M |
| Xtant Medical Holdings Inc | 98.88M |
| Catheter Precision Inc | 26.74M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 861.20M |
| Shareholders Equity (Quarterly) | 360.78M |
| Debt to Equity Ratio | 1.814 |
| Current Ratio | 1.490 |
| Net Debt Paydown Yield | -1.03% |